Phillips Wealth Planners LLC cut its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 38.2% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,758 shares of the healthcare conglomerate's stock after selling 1,086 shares during the period. Phillips Wealth Planners LLC's holdings in UnitedHealth Group were worth $541,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also bought and sold shares of the company. Bayforest Capital Ltd grew its position in shares of UnitedHealth Group by 685.7% in the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock valued at $29,000 after buying an additional 48 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd raised its stake in shares of UnitedHealth Group by 416.7% in the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock worth $32,000 after purchasing an additional 50 shares during the last quarter. IAG Wealth Partners LLC purchased a new stake in shares of UnitedHealth Group during the first quarter valued at approximately $42,000. Copia Wealth Management purchased a new stake in shares of UnitedHealth Group during the fourth quarter valued at approximately $42,000. Finally, O Brien Wealth Partners LLC increased its position in shares of UnitedHealth Group by 74.0% during the first quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate's stock valued at $46,000 after acquiring an additional 37 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.
Wall Street Analysts Forecast Growth
A number of research firms have recently commented on UNH. Sanford C. Bernstein raised their price target on UnitedHealth Group from $337.00 to $379.00 and gave the stock an "outperform" rating in a report on Friday, September 5th. Wells Fargo & Company decreased their price objective on UnitedHealth Group from $306.00 to $267.00 and set an "overweight" rating on the stock in a report on Monday, August 4th. Oppenheimer cut their price objective on UnitedHealth Group from $400.00 to $325.00 and set an "outperform" rating on the stock in a research report on Wednesday, July 30th. Barclays lifted their price objective on UnitedHealth Group from $337.00 to $352.00 and gave the company an "overweight" rating in a research report on Thursday, September 4th. Finally, JPMorgan Chase & Co. decreased their price objective on shares of UnitedHealth Group from $418.00 to $310.00 and set an "overweight" rating for the company in a report on Wednesday, August 6th. Sixteen equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the company's stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $358.95.
View Our Latest Report on UNH
UnitedHealth Group Stock Performance
Shares of NYSE:UNH traded up $10.54 on Tuesday, hitting $351.84. 6,425,206 shares of the company were exchanged, compared to its average volume of 12,971,463. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73. The stock's 50 day moving average price is $296.49 and its 200 day moving average price is $362.50. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The firm has a market capitalization of $318.65 billion, a P/E ratio of 15.21, a price-to-earnings-growth ratio of 2.20 and a beta of 0.44.
UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. During the same quarter in the previous year, the firm posted $6.80 earnings per share. The company's quarterly revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.
UnitedHealth Group Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be issued a $2.21 dividend. The ex-dividend date is Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. UnitedHealth Group's dividend payout ratio is presently 38.30%.
About UnitedHealth Group
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.